SFO
TXG icon

Standard Family Office’s 10x Genomics TXG Stock Holding History

Standard Family Office’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-776
Closed -$59K – 250
2022
Q1 		$59K Buy
+776
New +$67.9K 0.02% 54

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Standard Family Office's TXG Position: Q2 2022 in Review

Standard Family Office sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 776 shares — an estimated $59K sold.

Standard Family Office first reported a position in TXG in Q1 2022 and held it in 1 quarter. The position peaked at $59K in Q1 2022. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Standard Family Office reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Standard Family Office sold 776 10x Genomics shares in Q2 2022, an estimated $59K.
  • Standard Family Office first reported a position in 10x Genomics in Q1 2022 and held it in 1 quarter.
  • Standard Family Office's 10x Genomics position peaked at $59K in Q1 2022.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Standard Family Office's 13F filing for Q2 2022, filed 15 Aug 2022.